Göran Olivecrona
Latest contributions
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
Shock and PCI: due to ECMO I survived
22 May 2025 – From EuroPCR 2025
Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.
Hot topics in interventional management of out-of-hospital cardiac arrest (OHCA)
17 May 2024 – From EuroPCR 2024
This session explores the latest insights and strategies for managing out-of-hospital cardiac arrest (OHCA) patients. Key topics include identifying OHCA patients who may benefit from immediate cathlab admission, the default PCI strategy in OHCA, and how to organize an effective OHCA network. Discussions will cover estimating...
CTO within a bifurcation
16 May 2024 – From EuroPCR 2024
This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.
Upgrade to retrograde: when and how?
16 May 2024 – From EuroPCR 2024
This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.
Management complications during PCI of calcified coronary lesions
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions showcasing the management of complications that can arise during PCI (Percutaneous Coronary Intervention) of calcified coronary lesions. Participants will learn about various challenging scenarios, such as impacted diamond crown, stuck IVUS catheter post-stenting, and ruptured/fractured cutting balloon. The session...
Managing acute coronary perforation: a simulation-based team approach
18 May 2022 – From EuroPCR 2022
Acute heart failure: invasive treatment
23 May 2019 – From EuroPCR 2019
Consult this session on invasive treatment for acute heart failure and discover compelling clinical cases such as a triple ECMO therapy and dual PCI with stenting performed in a pediatric heart transplant patient, a catheter-directed thrombolysis in acute submassive pulmonary embolism, and more!
CTO intervention in patients with prior CABG
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about CTO intervention in patients with prior coronary artery bypass graft (CABG): challenges, tools, techniques, and more!
LIVE demonstration from St-Johannes Hospital - Dortmund, Germany: Antegrade CTO PCI
22 May 2019 – From EuroPCR 2019
Consult this session to discover the slides of this antegrade CTO PCI case, transmitted live during EuroPCR 2019: you will find out about the patient presentation and key clinical datas.
Assist devices for chronic heart failure
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about assist devices for chronic heart failure, and discover compelling cases such as: atrial septostomy for the management of heart failure, closure of subaortic VSD in a patient with three biological prosthesis, and more!
Trials and registries - Clinical outcomes after interventions with drug-coated balloons
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about the results of the latest trials and registries regarding the clinical outcomes after interventions with drug-coated balloons: SCAAR, BASKET-SMALL 2, EASTBOURNE, and more!
